Therapeutic Drug Monitoring in Pregnancy

Sarah C. Campbell, Laura M. Salisbury, Jessica K. Roberts, Manijeh Kamyar, Jeunesse Fredrickson, Maged Costantine, Catherine M T Sherwin

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

During pregnancy, important physiologic changes occur that affect pharmacokinetics and ultimately drug management. These include changes to renal and liver function, changes in serum protein levels, and the addition of a pharmacokinetic compartment (the infant and placenta) that is not present in the broader population. In addition, postpartum return to baseline physiology can further complicate drug management. This chapter examines therapeutic drug monitoring issues associated with pregnancy, including specific examples such as management of antidepressants.

Original languageEnglish (US)
Title of host publicationClinical Challenges in Therapeutic Drug Monitoring: Special Populations, Physiological Conditions, and Pharmacogenomics
PublisherElsevier Inc.
Pages185-211
Number of pages27
ISBN (Electronic)9780128020524
ISBN (Print)9780128020258
DOIs
StatePublished - May 17 2016

Fingerprint

Drug Monitoring
Pharmacokinetics
Pregnancy
Pharmaceutical Preparations
Postpartum Period
Placenta
Antidepressive Agents
Blood Proteins
Kidney
Liver
Population

Keywords

  • Altered drug disposition
  • Anticonvulsants
  • Antidepressants
  • Cardiac drugs
  • Pregnancy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Campbell, S. C., Salisbury, L. M., Roberts, J. K., Kamyar, M., Fredrickson, J., Costantine, M., & Sherwin, C. M. T. (2016). Therapeutic Drug Monitoring in Pregnancy. In Clinical Challenges in Therapeutic Drug Monitoring: Special Populations, Physiological Conditions, and Pharmacogenomics (pp. 185-211). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-802025-8.00008-8

Therapeutic Drug Monitoring in Pregnancy. / Campbell, Sarah C.; Salisbury, Laura M.; Roberts, Jessica K.; Kamyar, Manijeh; Fredrickson, Jeunesse; Costantine, Maged; Sherwin, Catherine M T.

Clinical Challenges in Therapeutic Drug Monitoring: Special Populations, Physiological Conditions, and Pharmacogenomics. Elsevier Inc., 2016. p. 185-211.

Research output: Chapter in Book/Report/Conference proceedingChapter

Campbell, SC, Salisbury, LM, Roberts, JK, Kamyar, M, Fredrickson, J, Costantine, M & Sherwin, CMT 2016, Therapeutic Drug Monitoring in Pregnancy. in Clinical Challenges in Therapeutic Drug Monitoring: Special Populations, Physiological Conditions, and Pharmacogenomics. Elsevier Inc., pp. 185-211. https://doi.org/10.1016/B978-0-12-802025-8.00008-8
Campbell SC, Salisbury LM, Roberts JK, Kamyar M, Fredrickson J, Costantine M et al. Therapeutic Drug Monitoring in Pregnancy. In Clinical Challenges in Therapeutic Drug Monitoring: Special Populations, Physiological Conditions, and Pharmacogenomics. Elsevier Inc. 2016. p. 185-211 https://doi.org/10.1016/B978-0-12-802025-8.00008-8
Campbell, Sarah C. ; Salisbury, Laura M. ; Roberts, Jessica K. ; Kamyar, Manijeh ; Fredrickson, Jeunesse ; Costantine, Maged ; Sherwin, Catherine M T. / Therapeutic Drug Monitoring in Pregnancy. Clinical Challenges in Therapeutic Drug Monitoring: Special Populations, Physiological Conditions, and Pharmacogenomics. Elsevier Inc., 2016. pp. 185-211
@inbook{204bb533112347b8abb0fec4888a0a94,
title = "Therapeutic Drug Monitoring in Pregnancy",
abstract = "During pregnancy, important physiologic changes occur that affect pharmacokinetics and ultimately drug management. These include changes to renal and liver function, changes in serum protein levels, and the addition of a pharmacokinetic compartment (the infant and placenta) that is not present in the broader population. In addition, postpartum return to baseline physiology can further complicate drug management. This chapter examines therapeutic drug monitoring issues associated with pregnancy, including specific examples such as management of antidepressants.",
keywords = "Altered drug disposition, Anticonvulsants, Antidepressants, Cardiac drugs, Pregnancy",
author = "Campbell, {Sarah C.} and Salisbury, {Laura M.} and Roberts, {Jessica K.} and Manijeh Kamyar and Jeunesse Fredrickson and Maged Costantine and Sherwin, {Catherine M T}",
year = "2016",
month = "5",
day = "17",
doi = "10.1016/B978-0-12-802025-8.00008-8",
language = "English (US)",
isbn = "9780128020258",
pages = "185--211",
booktitle = "Clinical Challenges in Therapeutic Drug Monitoring: Special Populations, Physiological Conditions, and Pharmacogenomics",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Therapeutic Drug Monitoring in Pregnancy

AU - Campbell, Sarah C.

AU - Salisbury, Laura M.

AU - Roberts, Jessica K.

AU - Kamyar, Manijeh

AU - Fredrickson, Jeunesse

AU - Costantine, Maged

AU - Sherwin, Catherine M T

PY - 2016/5/17

Y1 - 2016/5/17

N2 - During pregnancy, important physiologic changes occur that affect pharmacokinetics and ultimately drug management. These include changes to renal and liver function, changes in serum protein levels, and the addition of a pharmacokinetic compartment (the infant and placenta) that is not present in the broader population. In addition, postpartum return to baseline physiology can further complicate drug management. This chapter examines therapeutic drug monitoring issues associated with pregnancy, including specific examples such as management of antidepressants.

AB - During pregnancy, important physiologic changes occur that affect pharmacokinetics and ultimately drug management. These include changes to renal and liver function, changes in serum protein levels, and the addition of a pharmacokinetic compartment (the infant and placenta) that is not present in the broader population. In addition, postpartum return to baseline physiology can further complicate drug management. This chapter examines therapeutic drug monitoring issues associated with pregnancy, including specific examples such as management of antidepressants.

KW - Altered drug disposition

KW - Anticonvulsants

KW - Antidepressants

KW - Cardiac drugs

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=85011779245&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011779245&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-802025-8.00008-8

DO - 10.1016/B978-0-12-802025-8.00008-8

M3 - Chapter

SN - 9780128020258

SP - 185

EP - 211

BT - Clinical Challenges in Therapeutic Drug Monitoring: Special Populations, Physiological Conditions, and Pharmacogenomics

PB - Elsevier Inc.

ER -